Enveric Biosciences Inc. (ENVB)
NASDAQ: ENVB
· Real-Time Price · USD
1.08
-0.03 (-2.70%)
At close: Aug 15, 2025, 3:57 PM
1.09
0.98%
After-hours: Aug 15, 2025, 07:16 PM EDT
Enveric Biosciences Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.00 | -0.21 | -0.49 | -2.67 | -5.44 | -3.59 | -7.99 | -5.02 | -3.42 | -1.4 | 58.25 | -48.04 | -12.34 | -1.92 | -65.72 | -209.63 | -57.45 |
PEG Ratio | -0.00 | -0.00 | -0.00 | -0.08 | 0.09 | -0.29 | 0.14 | -0.14 | 0.05 | 0.00 | -0.44 | 0.58 | 0.13 | -0.00 | -0.37 | 2.66 | 0.60 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 76.17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.00 | 1.70 | 1.04 | 3.71 | 8.24 | 13.06 | 37.05 | 26.21 | 6.06 | 5.37 | 7.01 | 7.71 | 8.58 | 14.47 | 12.88 | 40.47 | 39.33 |
P/FCF Ratio | -0.00 | -2.06 | -4.45 | -6.94 | -20.56 | -28.15 | -32.93 | -28.61 | -12.27 | -22.74 | -35.02 | -36.51 | -41.48 | -75.84 | -323.2 | -376.68 | -194.66 |
P/OCF Ratio | -0.00 | -2.06 | -4.45 | -6.94 | -20.56 | -28.15 | -32.93 | -28.61 | -12.28 | -22.78 | -35.16 | -36.94 | -46.09 | -79.37 | -323.2 | -376.68 | -236.21 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -2.71 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | n/a | 0.01 | n/a |
Quick Ratio | 4.08 | 1.84 | 5.19 | 8.55 | 3.67 | 1.29 | 1.39 | 1.81 | 3.34 | 4.61 | 8.57 | 8.33 | 10.83 | 8.51 | 10.30 | 18.42 | 37.36 |
Current Ratio | 4.08 | 1.84 | 5.17 | 8.55 | 3.48 | 1.29 | 1.39 | 1.81 | 3.34 | 4.61 | 8.57 | 8.33 | 10.83 | 8.51 | 10.30 | 18.42 | 37.36 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | -3.56K | n/a | -1.54K | n/a | -441.88K | -90.78K | -18.37K | -7.05K | -1.16K | -9.95K | -9.51K | -697.58 | n/a |
Return on Equity | -0.56 | -1.98 | -0.53 | -0.35 | -0.38 | -0.91 | -1.16 | -1.31 | -0.44 | -0.96 | 0.03 | -0.04 | -0.17 | -1.89 | -0.05 | -0.05 | -0.17 |
Return on Assets | -0.43 | -1.02 | -0.44 | -0.31 | -0.28 | -0.56 | -0.43 | -0.65 | -0.29 | -0.72 | 0.02 | -0.03 | -0.13 | -1.58 | -0.04 | -0.04 | -0.13 |
Return on Invested Capital | -0.56 | -2 | -0.53 | -0.35 | -0.38 | -0.64 | -1.41 | -1.18 | -0.42 | -1.08 | 0.06 | -0.06 | -0.15 | -3.26 | -0.05 | -0.15 | -0.27 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.87 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -5.31 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -5.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -3.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -6.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |